We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New High Performance Microplate Reader for Clinical and Research Use

By LabMedica International staff writers
Posted on 24 Jun 2013
Print article
Image: The CLARIOstar microplate reader (Photo courtesy of BMG Labtech).
Image: The CLARIOstar microplate reader (Photo courtesy of BMG Labtech).
Image: The Clariostar's set of monochromators and filters guarantee enhance performance (Photo courtesy of BMG Labtech).
Image: The Clariostar's set of monochromators and filters guarantee enhance performance (Photo courtesy of BMG Labtech).
The new CLARIOstar microplate reader from BMG Labtech (Ortenberg, Germany) is the latest evolution in microplate reader instrumentation. This instrument is a multimode microplate reader with advanced LVF (linear variable filter) monochromators, highly sensitive filters, and an ultrafast spectrometer. It is a modular microplate reader, having up to eight different detection modes, including: fluorescence intensity, FRET, fluorescence polarization, luminescence, BRET, UV/Vis absorbance, time-resolved fluorescence, TR-FRET, and AlphaScreen/AphaLISA.

The proprietary AlphaScreen/AlphaLISA assays are performed with a high-energy laser. Kinetic and cell-based assays can be initiated with reagent injectors, and an integrated fluorophore library aids assay development and set up.

Advanced LVF monochromators having continually adjustable wavelengths (320 to 850 nm) and bandwidths (8 to 100 nm) for excitation and for emission significantly increase performance over conventional monochromators. Also, highly sensitive filters can be used in tandem with the advanced LVF monochromators for maximum versatility and sensitivity.

In addition to the advanced LVF monochromators for fluorescence and luminescence assays, the CLARIOstar integrates technologies that enhance other life science assays. Rapid, full spectrum UV/Vis absorbance (220 to 1,000 nm) is performed with BMG Labtech’s proprietary ultrafast spectrometer (less than one second per well). Cell-based assays are greatly improved with 0.1 mm Z-height resolution and cell layer scanning.

CLARIOstar's advanced monochromator system consists of two LVF monochromators and filter selectors, one for excitation and one for emission. In addition, a linear variable dichroic mirror (LVDM) slide is used to separate the excitation from the emission light. The LVF monochromator consists of a linear variable long pass (LVLP) slide and a linear variable short pass (LVSP) slide. The LVLP forms the rising edge while the LVSP forms the falling edge of a bandpass filter. By moving the LVLP and the LVSP slides relative to each other, the system creates a filter with a distinct variable peak wavelength and bandwidth. The manufacturer maintains that enhanced light transmission and better blocking of stray light significantly increase the performance of Clariostar when compared to conventional monochromators.

Related Links:
BMG Labtech

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.